PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 209 filers reported holding PTC THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $275,000 | -6.1% | 7,368 | 0.0% | 0.00% | – |
| Q4 2021 | $293,000 | +6.5% | 7,368 | -0.4% | 0.00% | – |
| Q3 2021 | $275,000 | +13.6% | 7,395 | +44.9% | 0.00% | – |
| Q1 2021 | $242,000 | -23.9% | 5,105 | -1.9% | 0.00% | -100.0% |
| Q4 2020 | $318,000 | -45.9% | 5,205 | -58.6% | 0.00% | -50.0% |
| Q3 2020 | $588,000 | -7.8% | 12,573 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $638,000 | +23.6% | 12,573 | +8.6% | 0.00% | 0.0% |
| Q1 2020 | $516,000 | +155.4% | 11,573 | +175.2% | 0.00% | +100.0% |
| Q4 2019 | $202,000 | -13.7% | 4,205 | -70.0% | 0.00% | 0.0% |
| Q4 2017 | $234,000 | +41.0% | 14,021 | +54.6% | 0.00% | 0.0% |
| Q2 2017 | $166,000 | +84.4% | 9,071 | -0.7% | 0.00% | – |
| Q1 2017 | $90,000 | +28.6% | 9,136 | +35.6% | 0.00% | – |
| Q4 2016 | $70,000 | +169.2% | 6,736 | +264.1% | 0.00% | – |
| Q3 2016 | $26,000 | +225.0% | 1,850 | +68.2% | 0.00% | – |
| Q2 2016 | $8,000 | -33.3% | 1,100 | -38.9% | 0.00% | – |
| Q1 2016 | $12,000 | -47.8% | 1,800 | +157.1% | 0.00% | – |
| Q4 2015 | $23,000 | +21.1% | 700 | 0.0% | 0.00% | – |
| Q3 2015 | $19,000 | +58.3% | 700 | +250.0% | 0.00% | – |
| Q1 2015 | $12,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AXON CAPITAL LP | 216,200 | $9,729,000 | 20.31% |
| GREAT POINT PARTNERS LLC | 1,974,385 | $88,847,000,000 | 9.86% |
| RTW INVESTMENTS, LP | 3,137,361 | $141,181,000 | 7.54% |
| Asymmetry Capital Management, L.P. | 280,542 | $12,624,000 | 6.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 259,000 | $11,642,000 | 4.32% |
| Boxer Capital, LLC | 1,000,000 | $45,000,000 | 3.87% |
| Opaleye Management Inc. | 226,388 | $10,187,000 | 3.10% |
| SECTORAL ASSET MANAGEMENT INC | 450,638 | $20,279,000 | 2.42% |
| SCOPIA CAPITAL MANAGEMENT LP | 983,005 | $44,235,000 | 1.96% |
| Chubb Ltd | 8,180 | $368,000 | 1.82% |